University of Maryland Medical System Corporation and Subsidiaries
Corrective Action Plan
Year Ended June 30, 2024
University of Maryland Medical System Corporation and Subsidiaries (the Corporation) considers the implementation and monitoring of effective internal controls to be one of its most i...
University of Maryland Medical System Corporation and Subsidiaries
Corrective Action Plan
Year Ended June 30, 2024
University of Maryland Medical System Corporation and Subsidiaries (the Corporation) considers the implementation and monitoring of effective internal controls to be one of its most important responsibilities. The Corporation respectfully submits the following corrective action plan regarding the Schedule of Findings and Questioned Costs for the year ended June 30, 2024.
Audit period: July 1, 2023 to June 30, 2024
FINDINGS—FEDERAL AWARD PROGRAMS AUDITS
2024-001 A. Activities Allowed or Unallowed; B. Allowable Costs/Cost Principles
Review and Approval of Purchase Orders
Assistance Listing 93.959: Block Grants for Substance Use Prevention, Treatment, and Recovery Services
Federal Agency: Department of Health and Human Services
Recommendation: Management should obtain documentation that evidences the review and approval of expenditures submitted to Behavioral Health System Baltimore (BHSB).
Explanation of disagreement with audit finding: There is no disagreement with the finding and recommendations.
Action planned/taken in response to finding: The Corporation went live on its new ERP system in April 2024. Since go-live, management has continued to optimize the system and find ways to strengthen our internal controls, including automating certain processes. Management will continue educating grant managers on system capabilities that can be utilized in the execution of review and approval of grant expenditures prior to submission to the relevant granting agencies for reimbursement. Centralized repositories have been set up for grant managers to extract specific monthly financial reports for use in the execution of their controls, as well as retain their review and approval evidence. For the specific vendor noted in Finding 2024-001, a grant input field has been added to the group purchasing orders to allow for enhanced tracking and review of expenditures associated with grants. Additionally, management is working with the vendor to ensure the requisition and approval configuration is properly maintained to prevent an approver in the from approving their own requisitions.
Anticipated Completion Date – June 30, 2026
Name(s) of the contact person(s) responsible for corrective action:
Jeff Chadwick, Financial Reporting Director, jeff.chadwick@umm.edu